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Background and Aims: Tamoxifen (Tam) is the most commonly used drug to treat estrogen 
receptor (ER)-positive breast cancers (BC). This drug is an estradiol antagonist, which has 
previously been demonstrated to restrain growth and trigger oxidative stress and cell death of ER-
positive breast cancer cells. In spite of the high effectiveness of endocrine therapy, onset of drug 
resistance accounts for both tumor recurrence and reduced survival of BC patients. Previous studies 
showed that autophagy is dysregulated in Tam-resistant BC cell lines and tumors, supporting the 
view that autophagy may critically contribute to drug resistance. 
Aim of this research is to gather further information on the putative mechanisms underlying Tam-
induced cell death and to better delineate the role of autophagy dysregulation in anticancer drug 
resistance in BC cells. 
Methods: Human ER-positive MCF7 cells were treated with Tam, after which viability (MTT 
assay) and clonogenic capability were measured. Integrity of the lysosomal compartment was 
assayed by staining the cells with either acridine orange or LysoTracker Red for live-cell 
microscopy, in basal conditions and following transient overexpression of metallothionein 2A 
(MT2A). 
Results: The results show that 20 µM Tam induces intense cellular vacuolization and cell death 
within hours. The acidic compartment is heavily affected already after 2 h of treatment: lysosomes 
lose their capability of either take up or to retain dyes such as acridine orange or LysoTracker Red, 
indicating that the drug elicits lysosomal membrane permeabilization (LMP). Tam also markedly 
reduces clonogenic survival of MCF7 cells; this effect is significantly abrogated by pretreatment 
with 100 µM vitamin E and, to a lower extent, with the iron chelator deferiprone. The finding that 
also LMP is effectively attenuated by vitamin E strongly supports the possibility that oxidative 
stress and intracellular iron play a key role in Tam-induced LMP and death. We have thus 
investigated whether overexpression of MT2A affected in some way Tam-induced LMP. MT2A-
overexpressing MCF7 cells evidenced a lysosomal localization of overexpressed MT2A and 
displayed a significantly reduced LMP compared to control cells. These data strongly support the 
view that dysregulation of iron-chelating proteins, as well as of their subcellular localization, 
markedly modulate cellular susceptibility to Tam-induced LMP. 
Conclusions: These preliminary results indicate that, at the concentrations used, Tam rapidly 
triggers LMP and cell death in MCF7 cells. These non-canonical and still poorly characterized 
biological effects seem to rely on oxidative stress and might prove to be important for anticancer 
activity of the drug. The results also show that Tam-induced LMP is effectively counteracted by 
overexpression of iron-chelating proteins, thus suggesting that the dysregulation of iron-binding 
proteins may contribute to increase the resistance of BC cells to anticancer drugs. 
